'Mission: Impossible' sues insurance company over 7 COVID shutdowns | Inquirer Entertainment
Close  

‘Mission: Impossible’ sues insurance company over 7 COVID shutdowns

/ 10:12 AM August 31, 2021
Actor Tom Cruise is seen on the set of "Mission Impossible 7" in Rome

Actor Tom Cruise is seen on the set of “Mission Impossible 7” while filming in Rome, Italy, Oct. 6, 2020. Image: Reuters/Yara Nardi

LOS ANGELES — Production on the new “Mission: Impossible” movie was shut down seven times due to the coronavirus pandemic, according to a lawsuit filed on Monday that accuses the film’s insurance company of failing to pay out for all but one of the costly stoppages.

Filming on the action series starring Tom Cruise was delayed four times in Italy, and three times in the United Kingdom between February 2020 and June 2021, said the lawsuit filed by Paramount Pictures in a United States federal court in California.

ADVERTISEMENT

The stoppages were caused by positive coronavirus tests among members of the cast or crew, or quarantine or lockdowns imposed in countries where the thriller was being filmed.

The lawsuit accuses Indiana-based Federal Insurance Company of breach of contract, saying it has agreed only to pay out $5 million for the first stoppage.

FEATURED STORIES

Federal Insurance did not immediately return a request for comment.

Cruise, who is also a producer on the film, lost his temper on the set of “Mission: Impossible 7” in England in December over a breach in COVID protocols, threatening to fire cast and crew members who did not take them seriously.

“Mission: Impossible” is one of the biggest franchises in Hollywood, with 2018’s “Mission: Impossible-Fallout” taking more than $791 million at the worldwide box office.

Multiple film and television productions have been disrupted by the pandemic and the cost of testing, consultants and protective equipment has added millions of dollars to their budgets.

Paramount said in the lawsuit that the insurance company argued there was “no evidence that those cast and crew members could not continue their duties, despite being infected with SARS-CoV-2 and posing an undeniable risk to other individuals involved with the production.”

Paramount did not say how much the shutdowns had cost but said its losses “far exceeded” the $5 million that Federal had agreed to pay for the first instance of coronavirus in February 2020.

Paramount is seeking a jury trial and unspecified damages.

ADVERTISEMENT

The delayed “Mission: Impossible 7” is due to be released in May 2022. JB

RELATED STORIES:

Tom Cruise in self-isolation, ‘Mission: Impossible 7’ shoots suspended after crew tested positive for COVID-19

For first movie in space, Russia races Tom Cruise and Elon Musk

The hottest entertainment news straight to your inbox

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: covid-19, health protocols, Insurance, Mission Impossible, Tom Cruise
For feedback, complaints, or inquiries, contact us.

Subscribe to our entertainment news

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.